Covid-19 vaccine-maker BioNTech to acquire former rival CureVac – POLITICO

Both German companies have continued mRNA programs on so-called cancer vaccines.

“We intend to bring together complementary capabilities and leverage technologies with the goal of advancing the development of innovative and transformative…